Skip to main content

Table 3 The most influential nodes in the mc_GBPN, selected by their TNCS across all centrality measures

From: Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma

Mc_GBPN Index

Node Description

TNCS

0

• X-linked Adrenoleukodystrophy (X-ALD)

• ABCD1 WT Allele, ABC42, AMN, ACOX1, ECK2921, ECK1408 genes

• VK-0214

4.407

12

• Ataxias, Choreas

• SETX, WASF1, GCH1 genes

5

38

• Absence Epilepsy

• CSTB, GABRA1, EC1 genes

3.986

27

• Amyotrophic Lateral Sclerosis (ALS)

• ALS1, ALS2, IGFALS genes

• Riluzole, Cannabidiol, Stem Cell Therapy

5

21

• Parkinson’s Disease

• FBXO7, DCTN1, GBA, PARK1, PARK2, PARK5, PARK6, PARK7, PARK8 genes

4.413

14

• Spastic Paraplegia 10 (SPG10)

• KIF5A gene

3.625

22

• Neurodegeneration with Brain Iron Accumulation 3 (NBIA3)

• FTL gene

5

16

• Rett Syndrome

• MECP2 gene

5

2

• Myoclonus Dystonia (M-D)

• SGCE gene

5

17

• CADASIL and CARASIL Syndromes

• NOTCH3, COL4A1, HTRA1 genes

• Cerebrolysin, Palm Tocotrienol Complex

5